Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) and Sapu Bioscience today announced key advancements in its global intellectual property portfolio supporting OT-101, its proprietary TGF-β ...
POTOMAC, MD / ACCESS Newswire / February 12, 2026 / IGC Pharma, Inc. ("IGC" or the "Company"), today announced that CEO Ram ...
New questions about lung cancer in ‘never-smokers’ As the number of people who smoke has gone down over the decades, those who never smoked have begun to make up a greater proportion of lung cancer ...